معرفی
Professor Eun-Yi Moon is affiliated with Sejong University's Department of Integrative Bioscience and Biotechnology. She holds a Ph.D. from Sungkyunkwan University (1997), an M.S. from KAIST (1989), and a B.S. from Seoul National University (1987).
- Education:
- Ph.D., Pharmacy, Sungkyunkwan University (1997)
- M.S., Biological Science, KAIST (1989)
- B.S., Pharmacy, Seoul National University (1987)
Her research focuses on tumorigenesis, cancer metastasis, anticancer drug resistance, tumor microenvironment, cell migration/EMT, and drug development for autoimmunity and tumors. She has published extensively on nano-therapeutics, reactive oxygen species (ROS), thymosin beta-4 mechanisms, and BAFF regulation in cancer and autoimmune contexts.
Recent publications include work on nanotechnology applications in anticancer therapy, glioblastoma targeting via enzyme inhibitors, and EMT inhibition in colorectal cancer through RAF/MEK/ERK pathways. Her team explores cilia-mediated tumor regulation, environmental toxicant impacts on B cell survival, and cross-talk between Nrf2/HIF-1α in hypoxic cancer cells.
Laboratory: Cell Molecular Physiology Laboratory (Chung 214) with research teams investigating drug resistance mechanisms, cancer microenvironment dynamics, and nanotoxicology. She has collaborated with institutions including Harvard Medical School, Boston Medical Center, and Korea Research Institutes.
